|
Derivation
|
The cells were reported to have originated from the synovial fluid in the knee joint of a patient suffering from degenerative arthritis.
|
|
Clinical Data
|
The cells were reported to have originated from the synovial fluid in the knee joint of a patient suffering from degenerative arthritis.
|
|
Comments
|
Little descriptive information about the origin of the McCoy cells appears in the literature. They were first mentioned by Pomerat, et al. [26143]. The cells were reported to have originated from the synovial fluid in the knee joint of a patient suffering from degenerative arthritis. In ca. 1965, Defendi, et al., showed that McCoy cells (designated McCoy A) were indeed human cells. However, another subline (designated McCoy B) was, in fact, of mouse origin and possessed marker chromosomes characteristic of strain L mouse fibroblasts. McCoy cells presumed to be human, but which actually are mouse cells, have been disseminated from laboratory to laboratory throughout the world. Initial interest in McCoy cells followed the demonstration by Gordon and Quan [PubMed ID: 14268619] and Gordon, et al., [PubMed ID: 4110420], that ionizing radiation (cobalt-60) greatly increased the susceptibility of McCoy cells to infection by chlamydia strains. A culture of the so-called McCoy cell line was received from the Centers for Disease Control, Cell Culture Department, Atlanta, GA in March, 1984. Documentation as to origin or passage history was not available. The cells have been used to propagate laboratory strains of the 15 recognized serotypes of Chlamydia trachomatis. The cell line has been satisfactory for chlamydia growth for at least 43 passages at ATCC. The cells are susceptible to chlamydia strains, and can be used to propagate chlamydia. Tested and found negative for ectromelia virus (mousepox).
|